|
Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle Clinical research trials and Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle. Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle clinical trial. Participants frequently obtain the most expert healthcare available for their Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "M" Clinical Trials Conditions > Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle  Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle
Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle
For Condition: Coronary Disease,Heart Diseases
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: Coronary artery disease (CAD) can cause poor blood flow and supply to the heart muscle. It can result in irreversible damage to the heart muscle and poor function. Before treating patients with heart disease it is important to know how well the heart is functioning. Echocardiography is a diagnostic test that can measure heart function. If part of the heart muscle is not working properly due to previous damage, echocardiography can provide information about how much improvement can be expected after treatment (surgery or angioplasty). The purpose of this study is to compare the accuracy of myocardial contrast echocardiography (MCE) to dobutamine echocardiography to detect the potential for damaged heart muscle to be treated and function in patients with heart disease. Myocardial contrast echocardiography (MCE) does not use radioactivity. It uses sound waves like standard echocardiography. However, with MCE patients receive an injection of a "contrast agent" directly into the blood stream through a vein. The contrast agent, called Optison, is made of tiny microbubbles smaller than red blood cells. The echocardiogram can detect these microbubbles in the small blood vessels of the heart muscle and allow researchers to find areas of the heart receiving less blood flow than others. Echocardiography with Dobutamine does not use radioactivity. It uses sound waves, like standard echocardiography. During this echocardiogram patients receive doses of a medication called dobutamine that stimulates the heart to beat stronger and faster. Heart muscle that does not beat stronger after dobutamine is probably dead, usually as a result of a previous heart attack.
Details: Doputamine echocardiography has become a valuable technique for the evaluation of myocardial viability in patients with coronary artery disease (CAD) and dysfunctional myocardium because it can accurately predict which myocardial segments will show contractile recovery after successful revascularization. Myocardial contrast echocardiography (MCE) offers the potential to evaluate tissue perfusion at the level where oxygen transfer to the myocytes occurs. MCE, therefore, can provide information regarding the functional status of the myocardial microvasculature which has a close relationship with myocellular integrity. The purpose of this study is to evaluate the accuracy of MCE compared to dobutamine echocardiography to detect myocardial viability in patients with CAD and resting wall motion abnormalities.
Eligibility:
Study Type: Interventional, Treatment, Efficacy
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Patients undergoing evaluation for CAD who show at least two myocardial segments with wall motion abnormalities on a baseline echocardiogram will be offered to participate in this study. Patients will be adults older than 21 years of age. No pre-menopausal patients who are lactating, are pregnant or potentially pregnant as judged by history, physical examination, ultrasound or urine pregnancy test. No one with unstable angina. No subjects with recent myocardial infarction (less than 1 month). No one with frequent ectopy which precludes adequate imaging acquisition. No subjects with significant hypertension (systolic blood pressure greater than 170 mm Hg). No hypotension with basal sitting systolic arterial pressure less than 100 mm HG confirmed 30 minutes later. No subjects with sinus tachycardia greater than or equal to 100 beats/minute. No atrial fibrillation. No inadequate two-dimensional echocardiographic windows.
Total Enrollment: 200
Location and Contact Information:
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 990108; 99-H-0108
Study Start Date: May 14, 1999
Record last reviewed: March 14, 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001891
Other Heart Diseases Studies:
1. Gender Response To Coronary Risk
2. Pawtucket Heart Health Program
3. Inflammation, Infection, and Future Cardiovascular Risk
4. Harvard Atherosclerosis Reversibility Project (HARP)
5. Trial of Aspirin and Vitamin E in Women (Women's Health Study - WHS)
Related Studies:
Other Heart Diseases Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle
|
|
|
|
|
|
|
|
